Viking Therapeutics Inc (VKTX)

41.82 -0.43 (-1.02%) USD  |  NASDAQ  |  Dec 23, 10:41
More

Viking Therapeutics Cash and Short Term Investments (Quarterly): 930.44M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for VKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Amgen Inc 9.011B
Eli Lilly and Co 3.518B
Pfizer Inc 9.952B
Merck & Co Inc 14.59B
Vertex Pharmaceuticals Inc 6.524B